Optimal Value-Based Therapy

Ken Schaecher, MD

Video Categories: Polycythemia Vera

Listen as Ken Schaecher, MD discusses the optimal value-based therapy for treatment of polycythemia vera.

Supported through funding from Incyte
January 16, 2019

Navigating the CMS 14-Day Rule in Biomarker Testing

Drs. David Rimm and Roy Herbst review the problems with the CMS “14-Day Rule” since some of the multigene panel biomarker tests require 21 days or longer to complete.

January 10, 2019

The Evolving Field of Treatment Modalities

Dr Morganna Freeman considers the future application of treatment modalities and how they might be combined for optimal results.